• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大豆蛋白及其异黄酮在预防非酒精性脂肪肝中的降脂作用——综述。

Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review.

机构信息

Nutrition Research Division, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, Ottawa, ON, K1A 0L2, Canada.

Food and Nutrition Science Program, Department of Chemistry, Carleton University, 1125 Colonel By Drive, Ottawa, ON, K1S 5B6, Canada.

出版信息

Plant Foods Hum Nutr. 2022 Sep;77(3):319-328. doi: 10.1007/s11130-022-00984-1. Epub 2022 Jun 9.

DOI:10.1007/s11130-022-00984-1
PMID:35678936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9463339/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and affects about 25% of the population globally. Obesity and diabetes are the main causes of the disease characterized by excessive accumulation of lipids in the liver. There is currently no direct pharmacological treatments for NAFLD. Dietary intervention and lifestyle modification are the key strategies in the prevention and treatment of the disease. Soy consumption is associated with many health benefits such as decreased incidence of coronary heart disease, type-2 diabetes, atherosclerosis and obesity. The hypolipidemic functions of soy components have been shown in both animal studies and human clinical trials. Dietary soy proteins and associated isoflavones suppressed the formation and accumulation of lipid droplets in the liver and improved NAFLD-associated metabolic syndrome. The molecular mechanism(s) underlying the effects of soy components are mainly through modulation of transcription factors, sterol regulatory element-binding protein-1 and peroxisome proliferator-activated receptor-γ2, and expressions of their target genes involved in lipogenesis and lipolysis as well as lipid droplet-promoting protein, fat-specific protein-27. Inclusion of appropriate amounts of soy protein and isoflavones in the diets might be a useful approach to decrease the prevalence of NAFLD and mitigate disease burden.

摘要

非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病,影响着全球约 25%的人口。肥胖症和糖尿病是这种疾病的主要病因,其特征是肝脏内脂质过度积累。目前,NAFLD 没有直接的药物治疗方法。饮食干预和生活方式改变是预防和治疗这种疾病的关键策略。大豆的食用与许多健康益处相关,如降低冠心病、2 型糖尿病、动脉粥样硬化和肥胖的发病率。大豆成分的降血脂功能在动物研究和人类临床试验中都得到了证实。膳食大豆蛋白和相关的异黄酮可抑制肝脏中脂质滴的形成和积累,并改善与 NAFLD 相关的代谢综合征。大豆成分作用的分子机制主要是通过调节转录因子、固醇调节元件结合蛋白-1 和过氧化物酶体增殖物激活受体-γ2 以及涉及脂肪生成和脂肪分解的靶基因的表达,以及促进脂质滴形成的蛋白、脂肪特异性蛋白-27。在饮食中适当摄入大豆蛋白和异黄酮可能是降低 NAFLD 患病率和减轻疾病负担的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af10/9463339/238cc61595a7/11130_2022_984_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af10/9463339/7841e2b5d047/11130_2022_984_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af10/9463339/238cc61595a7/11130_2022_984_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af10/9463339/7841e2b5d047/11130_2022_984_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af10/9463339/238cc61595a7/11130_2022_984_Fig2_HTML.jpg

相似文献

1
Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review.大豆蛋白及其异黄酮在预防非酒精性脂肪肝中的降脂作用——综述。
Plant Foods Hum Nutr. 2022 Sep;77(3):319-328. doi: 10.1007/s11130-022-00984-1. Epub 2022 Jun 9.
2
Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil.有效治疗脂肪肝的食物成分:大豆蛋白β-伴球蛋白和鱼油。
Int J Mol Sci. 2018 Dec 18;19(12):4107. doi: 10.3390/ijms19124107.
3
Effect of soy proteins and isoflavones on lipid metabolism and involved gene expression.大豆蛋白和异黄酮对脂质代谢及相关基因表达的影响。
Front Biosci. 2008 Jan 1;13:2660-73. doi: 10.2741/2873.
4
Low-3 Fatty Acid and Soy Protein Attenuate Alcohol-Induced Fatty Liver and Injury by Regulating the Opposing Lipid Oxidation and Lipogenic Signaling Pathways.低3脂肪酸和大豆蛋白通过调节相反的脂质氧化和生脂信号通路减轻酒精性脂肪肝和损伤。
Oxid Med Cell Longev. 2016;2016:1840513. doi: 10.1155/2016/1840513. Epub 2016 Dec 18.
5
Effects of soy protein and isoflavone on hepatic fatty acid synthesis and oxidation and mRNA expression of uncoupling proteins and peroxisome proliferator-activated receptor gamma in adipose tissues of rats.大豆蛋白和异黄酮对大鼠肝脏脂肪酸合成与氧化以及脂肪组织中解偶联蛋白和过氧化物酶体增殖物激活受体γ的mRNA表达的影响。
J Nutr Biochem. 2008 Oct;19(10):682-93. doi: 10.1016/j.jnutbio.2007.09.003. Epub 2008 Mar 6.
6
Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats.膳食补充大豆异黄酮或用大豆蛋白替代可防止肝脂滴蓄积,并改变参与大鼠脂质代谢的基因表达。
Genes Nutr. 2014 Jan;9(1):373. doi: 10.1007/s12263-013-0373-3. Epub 2013 Nov 30.
7
Fermented Soy Paste Alleviates Lipid Accumulation in the Liver by Regulating the AMPK Pathway and Modulating Gut Microbiota in High-Fat-Diet-Fed Rats.发酵豆酱通过调节 AMPK 通路和调节高脂肪饮食喂养大鼠的肠道微生物群来减轻肝脏脂质积累。
J Agric Food Chem. 2020 Sep 2;68(35):9345-9357. doi: 10.1021/acs.jafc.0c02919. Epub 2020 Aug 24.
8
Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease.大豆β-伴大豆球蛋白可改善非酒精性脂肪性肝病大鼠模型中肥胖诱导的代谢异常。
Obes Res Clin Pract. 2015 Mar-Apr;9(2):168-74. doi: 10.1016/j.orcp.2014.03.005. Epub 2014 Apr 29.
9
Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity).大豆异黄酮(大豆)改善高脂喂养的去卵巢Wistar大鼠(绝经后肥胖的实验模型)的高甘油三酯血症和肝脂肪变性。
J Nutr Biochem. 2016 Dec;38:57-69. doi: 10.1016/j.jnutbio.2016.08.007. Epub 2016 Sep 8.
10
The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial.补充大豆异黄酮对非酒精性脂肪性肝病患者代谢状态的影响:一项随机安慰剂对照临床试验。
BMC Public Health. 2024 May 21;24(1):1362. doi: 10.1186/s12889-024-18812-3.

引用本文的文献

1
Comparing Soy and Milk Protein Regulation of Hepatic Omega-3 Fatty Acid Biosynthesis.比较大豆蛋白和乳蛋白对肝脏ω-3脂肪酸生物合成的调节作用。
FASEB J. 2025 Jul 15;39(13):e70805. doi: 10.1096/fj.202501283R.
2
Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level.膳食大豆蛋白可逆转肥胖引起的肝脏脂肪变性,并改变粪便微生物组成,且与异黄酮水平无关。
Front Nutr. 2024 Oct 28;11:1487859. doi: 10.3389/fnut.2024.1487859. eCollection 2024.
3
Daidzein Inhibits Muscle Atrophy by Suppressing Inflammatory Cytokine- and Muscle Atrophy-Related Gene Expression.

本文引用的文献

1
Hepatic Proteomics Analysis of Nonalcoholic Fatty Liver Disease Obese Rat Model After Short- and Long-Term Soy Protein Isolate Feeding.非酒精性脂肪肝肥胖大鼠模型在短期和长期食用大豆分离蛋白后的肝蛋白质组学分析。
J Med Food. 2022 Mar;25(3):293-302. doi: 10.1089/jmf.2021.0088. Epub 2021 Dec 9.
2
Association between Equol Production Status and Nonalcoholic Steatohepatitis.大豆苷元产生状态与非酒精性脂肪性肝炎的关系。
Int J Mol Sci. 2021 Nov 2;22(21):11904. doi: 10.3390/ijms222111904.
3
Roles and mechanisms of NRG1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG1 modulates NAFLD through ErbB3 signaling).
大豆苷元通过抑制炎性细胞因子和肌肉萎缩相关基因的表达抑制肌肉萎缩。
Nutrients. 2024 Sep 13;16(18):3084. doi: 10.3390/nu16183084.
4
The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial.补充大豆异黄酮对非酒精性脂肪性肝病患者代谢状态的影响:一项随机安慰剂对照临床试验。
BMC Public Health. 2024 May 21;24(1):1362. doi: 10.1186/s12889-024-18812-3.
5
Anti-Hyperlipidemic Components of the Leaves of Synsepalum dulcificum (Miracle Fruit).神秘果叶的降脂成分。
Plant Foods Hum Nutr. 2024 Jun;79(2):451-459. doi: 10.1007/s11130-024-01152-3. Epub 2024 Mar 6.
6
Cholesterol Absorption Inhibition by Some Nutraceuticals.某些营养保健品对胆固醇吸收的抑制作用。
Recent Adv Food Nutr Agric. 2025;16(1):2-11. doi: 10.2174/012772574X285280240220065812.
7
The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women.胆碱、大豆异黄酮和益生菌作为辅助治疗在绝经后妇女非酒精性脂肪性肝病的预防和管理中的作用。
Nutrients. 2023 Jun 8;15(12):2670. doi: 10.3390/nu15122670.
8
Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017-2018.大豆苷元摄入量与代谢相关脂肪性肝病之间的关联:一项来自2017 - 2018年美国国家健康与营养检查调查(NHANES)的横断面研究。
Front Nutr. 2023 Feb 13;10:1113789. doi: 10.3389/fnut.2023.1113789. eCollection 2023.
NRG1 通过肝细胞中 ErbB3 信号调节 NAFLD 发病机制的作用和机制(NRG1 通过 ErbB3 信号调节 NAFLD)。
Obes Res Clin Pract. 2021 Mar-Apr;15(2):145-151. doi: 10.1016/j.orcp.2021.01.003. Epub 2021 Feb 2.
4
Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity.抑制 MNK 蛋白激酶可促进氧化代谢,预防饮食诱导的肥胖。
Mol Metab. 2020 Dec;42:101054. doi: 10.1016/j.molmet.2020.101054. Epub 2020 Jul 23.
5
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.2019-2030 年加拿大非酒精性脂肪性肝病负担:建模研究。
CMAJ Open. 2020 Jun 9;8(2):E429-E436. doi: 10.9778/cmajo.20190212. Print 2020 Apr-Jun.
6
Soy β-Conglycinin Peptide Attenuates Obesity and Lipid Abnormalities in Obese Model OLETF Rats.大豆β-伴大豆球蛋白肽减轻肥胖模型OLETF大鼠的肥胖和脂质异常。
J Oleo Sci. 2020;69(5):495-502. doi: 10.5650/jos.ess20010.
7
Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population.以植物为基础、高纤维的饮食模式与老年人群中非酒精性脂肪肝的消退有关。
Eur J Epidemiol. 2020 Nov;35(11):1069-1085. doi: 10.1007/s10654-020-00627-2. Epub 2020 Apr 22.
8
Modelling NAFLD disease burden in four Asian regions-2019-2030.2019 - 2030年四个亚洲地区非酒精性脂肪性肝病疾病负担建模
Aliment Pharmacol Ther. 2020 Apr;51(8):801-811. doi: 10.1111/apt.15673. Epub 2020 Mar 4.
9
Nonalcoholic fatty liver disease burden: Australia, 2019-2030.非酒精性脂肪性肝病负担:澳大利亚,2019-2030 年。
J Gastroenterol Hepatol. 2020 Sep;35(9):1628-1635. doi: 10.1111/jgh.15009. Epub 2020 Feb 26.
10
The effects of isolated soy protein, isolated soy isoflavones and soy protein containing isoflavones on serum lipids in postmenopausal women: A systematic review and meta-analysis.大豆分离蛋白、大豆异黄酮和富含异黄酮的大豆蛋白对绝经后妇女血脂的影响:系统评价和荟萃分析。
Crit Rev Food Sci Nutr. 2020;60(20):3414-3428. doi: 10.1080/10408398.2019.1689097. Epub 2019 Dec 20.